DK1710241T3 - Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol - Google Patents
Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrolInfo
- Publication number
- DK1710241T3 DK1710241T3 DK06112333.7T DK06112333T DK1710241T3 DK 1710241 T3 DK1710241 T3 DK 1710241T3 DK 06112333 T DK06112333 T DK 06112333T DK 1710241 T3 DK1710241 T3 DK 1710241T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxepino
- dibenz
- pyrrole
- tetrahydro
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05102742 | 2005-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1710241T3 true DK1710241T3 (da) | 2010-03-01 |
Family
ID=35511130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06112333.7T DK1710241T3 (da) | 2005-04-07 | 2006-04-06 | Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol |
Country Status (28)
Country | Link |
---|---|
EP (2) | EP2154134B1 (da) |
JP (1) | JP2008534657A (da) |
KR (1) | KR20070116973A (da) |
CN (2) | CN101175741B (da) |
AR (1) | AR063188A1 (da) |
AT (1) | ATE447564T1 (da) |
AU (1) | AU2006231281B2 (da) |
BR (1) | BRPI0610677A2 (da) |
CA (1) | CA2603181A1 (da) |
CY (1) | CY1109722T1 (da) |
DE (1) | DE602006010132D1 (da) |
DK (1) | DK1710241T3 (da) |
ES (1) | ES2333980T3 (da) |
HK (1) | HK1094800A1 (da) |
HR (1) | HRP20100031T1 (da) |
IL (1) | IL186354A0 (da) |
MX (1) | MX2007012446A (da) |
NO (1) | NO20075152L (da) |
NZ (1) | NZ562125A (da) |
PL (1) | PL1710241T3 (da) |
PT (1) | PT1710241E (da) |
RS (1) | RS51341B (da) |
RU (1) | RU2397164C2 (da) |
SI (1) | SI1710241T1 (da) |
TW (1) | TW200716589A (da) |
UA (2) | UA93043C2 (da) |
WO (1) | WO2006106136A1 (da) |
ZA (2) | ZA200708493B (da) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5027477B2 (ja) * | 2005-10-21 | 2012-09-19 | 住友化学株式会社 | ジベンゾオキセピノピロール化合物およびその中間体の製造方法ならびに新規中間体 |
TW200817414A (en) * | 2006-07-05 | 2008-04-16 | Organon Nv | Process for the preparation of asenapine and intermediate products used in said process |
CN101563312A (zh) * | 2006-12-22 | 2009-10-21 | 住友化学株式会社 | 阿塞那平合成中间体的制备方法 |
US7875729B2 (en) * | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine |
JP5245428B2 (ja) | 2007-07-06 | 2013-07-24 | 住友化学株式会社 | トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体 |
CA2710800A1 (en) * | 2008-01-04 | 2009-07-16 | N.V. Organon | Process for the preparation of asenapine and intermediate products used in said process |
TW201113018A (en) | 2009-06-24 | 2011-04-16 | Organon Nv | Injectable formulations containing asenapine and method of treatment using same |
CN101851242B (zh) * | 2010-05-25 | 2013-07-24 | 上海皓元生物医药科技有限公司 | 阿塞那平中间体的制备方法 |
EP2598496B1 (en) | 2010-07-29 | 2014-03-19 | Laboratorios Lesvi, S.L. | Novel process for the preparation of asenapine |
WO2012038975A2 (en) * | 2010-09-22 | 2012-03-29 | Msn Laboratories Limited | Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof |
EP2468751B1 (en) | 2010-12-24 | 2016-03-16 | Medichem, S.A. | Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
ITMI20110734A1 (it) * | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
WO2013024492A2 (en) | 2011-07-01 | 2013-02-21 | Megafine Pharma (P) Ltd. | A process for the preparation of asenapine and novel salts thereof |
CN102952144A (zh) * | 2011-08-29 | 2013-03-06 | 上海华拓医药科技发展股份有限公司 | 阿森纳平马来酸盐的晶型、制备方法及其药物组合物 |
WO2013080069A1 (en) * | 2011-11-28 | 2013-06-06 | Ranbaxy Laboratories Limited | Process for the preparation of asenapine intermediate |
CN102746209A (zh) * | 2012-06-20 | 2012-10-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种3-(2-(4-氯苯氧基)苯基)-1-甲基-2,4-二酮的合成方法 |
CN103965206A (zh) * | 2013-01-29 | 2014-08-06 | 北京京卫燕康药物研究所有限公司 | 一种阿色纳品马来酸盐的新晶型及制备方法 |
CN103113379A (zh) * | 2013-03-12 | 2013-05-22 | 盛世泰科生物医药技术(苏州)有限公司 | 阿塞那平马来酸盐的合成工艺 |
CN103254202A (zh) * | 2013-05-19 | 2013-08-21 | 甘肃皓天化学科技有限公司 | 阿塞纳平的制备方法 |
CN103342707B (zh) * | 2013-06-28 | 2015-09-02 | 甘肃皓天化学科技有限公司 | 用于制备阿塞纳平中间体的制备方法 |
CN104447771A (zh) * | 2013-09-12 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 一种稳定的马来酸阿塞那平化合物 |
CN103864802B (zh) * | 2014-03-31 | 2016-08-17 | 四川科伦药业股份有限公司 | 马来酸阿塞那平的制备方法 |
CN105693735A (zh) * | 2016-01-15 | 2016-06-22 | 万特制药(海南)有限公司 | 马来酸阿塞那平一种制备方法 |
MX2019007391A (es) | 2016-12-20 | 2019-08-16 | Lts Lohmann Therapie Systeme Ag | Sistema terapeutico transdermico que contiene asenapina. |
EP3558276A1 (en) | 2016-12-20 | 2019-10-30 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
WO2019002204A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER |
CN109200025A (zh) * | 2017-06-29 | 2019-01-15 | 哈尔滨莱博通药业有限公司 | 一种阿森纳平马来酸盐舌下片 |
WO2019243452A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
CN110183457A (zh) * | 2019-06-27 | 2019-08-30 | 浙江天顺药业有限公司 | 一种阿塞那平及其制备方法 |
CN112194665A (zh) * | 2020-10-20 | 2021-01-08 | 连云港杰瑞药业有限公司 | 一种合成阿塞那平中间体的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
HU225051B1 (en) | 1994-03-02 | 2006-05-29 | Organon Ireland Ltd | Sublingual or buccal pharmaceutical compositions containing trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
WO1999032108A1 (en) | 1997-12-19 | 1999-07-01 | Akzo Nobel N.V. | Org-5222 in the treatment of depression |
-
2006
- 2006-04-06 CN CN2006800167535A patent/CN101175741B/zh not_active Expired - Fee Related
- 2006-04-06 SI SI200630526T patent/SI1710241T1/sl unknown
- 2006-04-06 UA UAA200711019A patent/UA93043C2/ru unknown
- 2006-04-06 WO PCT/EP2006/061409 patent/WO2006106136A1/en not_active Application Discontinuation
- 2006-04-06 AT AT06112333T patent/ATE447564T1/de not_active IP Right Cessation
- 2006-04-06 MX MX2007012446A patent/MX2007012446A/es active IP Right Grant
- 2006-04-06 DK DK06112333.7T patent/DK1710241T3/da active
- 2006-04-06 JP JP2008504777A patent/JP2008534657A/ja not_active Withdrawn
- 2006-04-06 EP EP09174540A patent/EP2154134B1/en active Active
- 2006-04-06 RS RSP-2010/0014A patent/RS51341B/en unknown
- 2006-04-06 RU RU2007141161/04A patent/RU2397164C2/ru not_active IP Right Cessation
- 2006-04-06 CA CA002603181A patent/CA2603181A1/en not_active Abandoned
- 2006-04-06 ES ES06112333T patent/ES2333980T3/es active Active
- 2006-04-06 DE DE602006010132T patent/DE602006010132D1/de active Active
- 2006-04-06 EP EP06112333A patent/EP1710241B1/en active Active
- 2006-04-06 AR ARP060101357A patent/AR063188A1/es unknown
- 2006-04-06 CN CN2006100916992A patent/CN1861604B/zh active Active
- 2006-04-06 NZ NZ562125A patent/NZ562125A/en not_active IP Right Cessation
- 2006-04-06 KR KR1020077025399A patent/KR20070116973A/ko not_active Application Discontinuation
- 2006-04-06 PT PT06112333T patent/PT1710241E/pt unknown
- 2006-04-06 TW TW095112190A patent/TW200716589A/zh unknown
- 2006-04-06 UA UAA200711020A patent/UA93044C2/ru unknown
- 2006-04-06 PL PL06112333T patent/PL1710241T3/pl unknown
- 2006-04-06 AU AU2006231281A patent/AU2006231281B2/en not_active Ceased
- 2006-04-06 BR BRPI0610677-3A patent/BRPI0610677A2/pt not_active IP Right Cessation
-
2007
- 2007-02-26 HK HK07102138.2A patent/HK1094800A1/xx not_active IP Right Cessation
- 2007-10-04 ZA ZA200708493A patent/ZA200708493B/xx unknown
- 2007-10-04 ZA ZA200708490A patent/ZA200708490B/xx unknown
- 2007-10-07 IL IL186354A patent/IL186354A0/en not_active IP Right Cessation
- 2007-10-10 NO NO20075152A patent/NO20075152L/no not_active Application Discontinuation
-
2010
- 2010-01-08 CY CY20101100023T patent/CY1109722T1/el unknown
- 2010-01-18 HR HR20100031T patent/HRP20100031T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1710241T3 (da) | Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol | |
CY2012021I1 (el) | Παραγωγα πυρρολο[2,3-β]πυριδινης ως αναστολεις κινασης πρωτεϊνης | |
DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
IL183764A0 (en) | Bicyclic pyrrole derivatives | |
DK1797099T3 (da) | Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser | |
DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
HK1101304A1 (en) | Bicyclic anthranilamide derivatives useful as insecticides | |
DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
HK1163672A1 (en) | Processes for the preparation of compounds | |
HRP20070429T3 (en) | Crystal form of asenapine maleate | |
DK1846376T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid | |
IL183647A (en) | The heterocyclic compounds are converted into 3-ethylidenehydrazino | |
DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
NL1030503A1 (nl) | Octahydropyrrolo[3,4-c]-pyrroolderivaten. | |
BRPI0822239A2 (pt) | Composto de pirazolo[1,5-a] pirimidina | |
DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
DK1667967T3 (da) | Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater | |
DE602005010986D1 (de) | Neue pyrrolidin-3,4-dicarbonsäureamidderivate | |
DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
IL191568A0 (en) | Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2-one | |
DK1912961T3 (da) | Fremgangsmåde til fremstilling af bepromolin | |
EP1928827A4 (en) | PYRROLE DERIVATIVES AS THERAPEUTIC AGENTS | |
HK1105634A1 (en) | Heteroatoms-containing tricyclic compounds | |
DK1937662T3 (da) | Fremgangsmåde til fremstilling af duloxetin |